DK169542B1 - Substituerede 3-piperidinaminer eller 3-hexahydroazepinaminer, deres fremstilling og farmaceutiske præparater indeholdende dem - Google Patents

Substituerede 3-piperidinaminer eller 3-hexahydroazepinaminer, deres fremstilling og farmaceutiske præparater indeholdende dem Download PDF

Info

Publication number
DK169542B1
DK169542B1 DK669787A DK669787A DK169542B1 DK 169542 B1 DK169542 B1 DK 169542B1 DK 669787 A DK669787 A DK 669787A DK 669787 A DK669787 A DK 669787A DK 169542 B1 DK169542 B1 DK 169542B1
Authority
DK
Denmark
Prior art keywords
methyl
formula
process according
compounds
compounds according
Prior art date
Application number
DK669787A
Other languages
Danish (da)
English (en)
Other versions
DK669787D0 (da
DK669787A (da
Inventor
Patrick Carlier
Jacques Aime-Louis Simond
Andre Jean-Claude Monteil
Original Assignee
Cerm Cent Europ Rech Mauvernay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerm Cent Europ Rech Mauvernay filed Critical Cerm Cent Europ Rech Mauvernay
Publication of DK669787D0 publication Critical patent/DK669787D0/da
Publication of DK669787A publication Critical patent/DK669787A/da
Application granted granted Critical
Publication of DK169542B1 publication Critical patent/DK169542B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK669787A 1986-12-23 1987-12-18 Substituerede 3-piperidinaminer eller 3-hexahydroazepinaminer, deres fremstilling og farmaceutiske præparater indeholdende dem DK169542B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8618083A FR2608602A1 (fr) 1986-12-23 1986-12-23 Nouvelles 3-piperidineamines ou 3-azepineamines substituees, leur preparation et leurs applications en therapeutique
FR8618083 1986-12-23

Publications (3)

Publication Number Publication Date
DK669787D0 DK669787D0 (da) 1987-12-18
DK669787A DK669787A (da) 1988-06-24
DK169542B1 true DK169542B1 (da) 1994-11-28

Family

ID=9342239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK669787A DK169542B1 (da) 1986-12-23 1987-12-18 Substituerede 3-piperidinaminer eller 3-hexahydroazepinaminer, deres fremstilling og farmaceutiske præparater indeholdende dem

Country Status (17)

Country Link
US (1) US4822792A (ko)
EP (1) EP0275759B1 (ko)
JP (1) JP2568235B2 (ko)
KR (1) KR960000073B1 (ko)
AT (1) ATE72237T1 (ko)
AU (1) AU600326B2 (ko)
CA (1) CA1319145C (ko)
DE (1) DE3776546D1 (ko)
DK (1) DK169542B1 (ko)
ES (1) ES2032301T3 (ko)
FI (1) FI84266C (ko)
FR (1) FR2608602A1 (ko)
GR (1) GR3004452T3 (ko)
IE (1) IE61310B1 (ko)
NZ (1) NZ222972A (ko)
PT (1) PT86444B (ko)
ZA (1) ZA879430B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA122433C2 (uk) 2016-02-04 2020-11-10 Такеда Фармасьютікал Компані Лімітед Заміщена піперидинова сполука та її застосування
JP7339250B2 (ja) * 2018-06-29 2023-09-05 武田薬品工業株式会社 複素環化合物およびその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4208418A (en) * 1975-09-23 1980-06-17 Janssen Pharmaceutica N.V. N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides
US4097481A (en) * 1976-11-08 1978-06-27 Riker Laboratories, Inc. Tertiary amide derivatives of pyrrolidine and piperidine
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds

Also Published As

Publication number Publication date
AU600326B2 (en) 1990-08-09
KR960000073B1 (ko) 1996-01-03
ATE72237T1 (de) 1992-02-15
FI84266B (fi) 1991-07-31
DK669787D0 (da) 1987-12-18
FI875653A (fi) 1988-06-24
FI84266C (fi) 1991-11-11
CA1319145C (en) 1993-06-15
JP2568235B2 (ja) 1996-12-25
FR2608602A1 (fr) 1988-06-24
EP0275759A1 (fr) 1988-07-27
PT86444B (pt) 1990-11-20
FI875653A0 (fi) 1987-12-22
DE3776546D1 (de) 1992-03-12
IE873513L (en) 1988-06-23
ZA879430B (en) 1988-06-10
IE61310B1 (en) 1994-10-19
GR3004452T3 (ko) 1993-03-31
ES2032301T3 (es) 1993-02-01
JPS63190876A (ja) 1988-08-08
PT86444A (en) 1988-01-01
NZ222972A (en) 1990-01-29
DK669787A (da) 1988-06-24
KR880007463A (ko) 1988-08-27
US4822792A (en) 1989-04-18
EP0275759B1 (fr) 1992-01-29
AU8285687A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
AU600769B2 (en) Tetrahydronaphthalene derivatives
DK152209B (da) Analogifremgangsmaade til fremstilling af 1-oe(acyltio)- eller (merkapto)-1-oxoalkylaa-1,2,3,4-tetrahydrokinolin-2-karboxylsyrer eller natrium- eller dicyklohexylaminsalte deraf
HUT73526A (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
JPH07157469A (ja) ピペリジン誘導体
US5965600A (en) 3-(bis-substituted phenylmethylene) oxindole derivatives
DK169542B1 (da) Substituerede 3-piperidinaminer eller 3-hexahydroazepinaminer, deres fremstilling og farmaceutiske præparater indeholdende dem
JP2802437B2 (ja) 鎮痛作用を有する化合物、その製法ならびに該化合物を含む鎮痛剤
FI83317C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla i 11-staellning substituerade 5,11-dihydro-6h -pyrido/2,3-b//1,4/bensodiazepin-6-oner.
US5314895A (en) Benzopyran class III antiarrhythmic agents
US4820702A (en) New substituted piperidine or azepine compounds which have useful calcium-antagonistic activity
HU194213B (en) Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins
EP0508995B1 (en) Muscarinic receptor antagonists
CS239947B2 (en) Processing of new benzazepin derivatives
GB2044251A (en) Phenoxypropanolamine derivatives
EP0452107A1 (en) Pyrimidinedione derivatives and antiarrythmic agents containing same
EP0104647A2 (en) Pyridopyrimidinones
ES2198947T3 (es) Derivados de azabicicloheptano n-substituidos, su obtencion y empleo.
JPWO2002096891A1 (ja) ジヒドロジアリールオキサゼピン誘導体及び該誘導体を含有する医薬組成物
FR2640975A1 (ko)
JPS62226977A (ja) ピリジン誘導体
JPH09169743A (ja) ヘキサヒドロ−１ｈ−１，４−ジアゼピン誘導体、その製造方法およびその医薬用途
HU191585B (en) Process for producing tetramethyl-proline-3-carboxamide derivatives and new cardiotherapeutic compositions containing them
FR2634204A2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleines, leur preparation et leur application en therapeutique
BE869191A (fr) Nouvelles imidazo-isoquinoleine-diones, procedes pour leur preparation et leur utilisation en tant que medicaments

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed